Table 7.
Effectiveness of vaccines against variant of interests of SARS-CoV-2 strains. The details on name of the vaccines and variants of SARS-CoV-2 interest strains with their references.
| Vaccines | Variant of interest |
|||||||
|---|---|---|---|---|---|---|---|---|
| Epsilon | Zeta | Eta | Theta | Iota | Kappa | Lambda | Mu | |
| Moderna | Neutralizing antibodies [147] | NA | NA | NA | 94-95% [148] | NA | Neutralizing antibodies [149] | 94% [150] |
| BNT162b2 | Neutralizing antibodies [151] | Neutralizing antibodies [152] | Neutralizing antibodies [153] | Neutralizing antibodies [146] | 94-95% [148] | Neutralizing antibodies [153] | Neutralizing antibodies [123] | Neutralizing antibodies [154] |
| Ad26.CoV2.S | 66% [155] | 66% [155] | NA | NA | 66% [155] | NA | NA | NA |
| ChAdOx1 nCoV-19 | 55-81% [[123], [148]] | 55-81% [[123], [148]] | NA | NA | 55-81% [123] | NA | 55-81% [123] | NA |
| NVX-CoV2373 | 89% [156] | NA | NA | NA | 89% [156] | NA | 66% [148] | NA |
| Covaxin | NA | NA | NA | NA | 78% [148] | NA | NA | |
| Corona Vac | No difference in neutralizing antibodies [157] | Neutralizing antibodies [158] | NA | NA | Neutralizing antibodies [158] | NA | NA | NA |
Abbreviations: NA-not available.